Reply to 'Switch from ustekinumab to guselkumab in patients with psoriasis in real clinical practice using the 'minimal disease activity' parameter'

Authors :: Giulia Murgia
Carlo Alberto Maronese
Carlo Giovanni Carrera
Angelo Cattaneo
Angelo Valerio Marzano
Source :: Dermatologic therapy. 35(8)
Publication Year :: 2022

Subjects :: Settore MED/35 - Malattie Cutanee e Veneree
Antibodies, Monoclonal, Humanized
Humans
Psoriasis
Ustekinumab
Monoclonal
Dermatology
General Medicine
Humanized
Antibodies

Tools